Lathyrism
Lathyrism is a neurological disease caused by the consumption of certain legumes from the genus Lathyrus, particularly the species Lathyrus sativus (also known as grass pea, chickling vetch, or Indian pea). The disease is characterized by progressive spastic paraplegia, which results in a stiff and awkward gait.
Etiology
Lathyrism is caused by the ingestion of the neurotoxin β-N-oxalyl-L-α,β-diaminopropionic acid (ODAP), also known as β-L-oxalylamino-L-alanine (BOAA). This compound is found in high concentrations in the seeds of Lathyrus sativus and other Lathyrus species. The toxin is resistant to cooking and other forms of food processing.
Epidemiology
Lathyrism is most commonly found in regions where Lathyrus sativus is a staple food, particularly during times of famine. This includes parts of South Asia, East Africa, and the Mediterranean region. The disease is more prevalent in males, possibly due to their higher consumption of Lathyrus seeds.
Clinical Presentation
The symptoms of lathyrism typically begin with weakness and stiffness in the legs. This progresses to spastic paraplegia, a condition characterized by increased muscle tone and spasms in the lower limbs. Other symptoms may include numbness, tingling, and pain in the affected limbs. In severe cases, the disease can lead to complete paralysis.
Diagnosis
Diagnosis of lathyrism is primarily based on the patient's dietary history and clinical symptoms. Laboratory tests may be used to detect the presence of ODAP in the patient's blood or urine.
Treatment and Prevention
There is currently no cure for lathyrism. Treatment is focused on managing symptoms and preventing further consumption of Lathyrus seeds. Physical therapy may be beneficial for improving mobility and reducing muscle stiffness. Prevention strategies include education about the risks of consuming Lathyrus seeds and promoting alternative food sources.
See Also

This article is a toxicology-related stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian